Inozyme Pharma Inc (INZY) — Long-term Investment Intensity
Inozyme Pharma Inc (INZY) has a Long-term Investment Intensity of 1.6% as of March 2021. Long-term investments of $2.55 Million represent 1.6% of total assets of $158.91 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Inozyme Pharma Inc (INZY) shareholders funds for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Inozyme Pharma Inc Long-term Investment Intensity (2020–2020)
This chart shows how Inozyme Pharma Inc's Long-term Investment Intensity has evolved across 1 annual periods from 2020 to 2020. As of March 2021, the intensity stands at 1.6%, reflecting long-term investments of $2.55 Million against total assets of $158.91 Million USD. Also explore balance sheet size of Inozyme Pharma Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Inozyme Pharma Inc (2020–2020)
The table below presents the year-by-year Long-term Investment Intensity for Inozyme Pharma Inc from 2020 to 2020, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Inozyme Pharma Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2020 | 7.2% | $12.20 Million | $169.36 Million | — |